Apollo Hospitals Enterprise (APOLLOHOSP) Stock Overview
Provides healthcare services in India. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for APOLLOHOSP from our risk checks.
APOLLOHOSP Community Fair Values
Create NarrativeSee what 26 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Apollo Hospitals Enterprise Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹8,176.50 |
| 52 Week High | ₹8,443.00 |
| 52 Week Low | ₹6,696.50 |
| Beta | 0.16 |
| 1 Month Change | 7.07% |
| 3 Month Change | 4.54% |
| 1 Year Change | 18.84% |
| 3 Year Change | 64.61% |
| 5 Year Change | 141.90% |
| Change since IPO | 47,856.01% |
Recent News & Updates
Analysis Article • May 23
Earnings Update: Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
It's been a good week for Apollo Hospitals Enterprise Limited ( NSE:APOLLOHOSP ) shareholders, because the company has...
Narrative Update • May 12
APOLLOHOSP: Dwarka Hospital Development And Steady Forecasts Will Support Balanced Long Term Outlook
The analyst price target for Apollo Hospitals Enterprise has been adjusted slightly higher to about ₹8,802 from roughly ₹8,769, as analysts fine tune their assumptions on discount rate, profit margin and forward P/E while keeping revenue growth expectations broadly unchanged. What's in the News A board meeting is scheduled for May 20, 2026 to review and approve the annual audited standalone financial results for the three months and year ended March 31, 2026, along with other matters, including consideration of a final dividend for FY 2025-2026 (Key Developments).Recent updates
Analysis Article • May 23
Earnings Update: Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
It's been a good week for Apollo Hospitals Enterprise Limited ( NSE:APOLLOHOSP ) shareholders, because the company has...Narrative Update • May 12
APOLLOHOSP: Dwarka Hospital Development And Steady Forecasts Will Support Balanced Long Term Outlook
The analyst price target for Apollo Hospitals Enterprise has been adjusted slightly higher to about ₹8,802 from roughly ₹8,769, as analysts fine tune their assumptions on discount rate, profit margin and forward P/E while keeping revenue growth expectations broadly unchanged. What's in the News A board meeting is scheduled for May 20, 2026 to review and approve the annual audited standalone financial results for the three months and year ended March 31, 2026, along with other matters, including consideration of a final dividend for FY 2025-2026 (Key Developments).Narrative Update • Apr 26
APOLLOHOSP: New Delhi Dwarka Expansion Will Support Long Term Upside Potential
Analysts have nudged their price target on Apollo Hospitals Enterprise slightly lower to ₹8,768.57 from ₹8,770.23, reflecting small adjustments to fair value, revenue growth, profit margin, and future P/E assumptions in their models. What's in the News The Board of Directors approved the establishment of a multi-speciality hospital at Dwarka, New Delhi at the meeting held on April 2, 2026 (Key Developments).Narrative Update • Apr 12
APOLLOHOSP: New Dwarka Hospital Project Will Support Future Upside
Analysts have made a small downward adjustment to the fair value estimate for Apollo Hospitals Enterprise, with the price target moving from about ₹8,793.50 to approximately ₹8,770. This reflects refreshed assumptions on revenue growth, profit margins and future P/E levels.Narrative Update • Mar 28
APOLLOHOSP: Dividend Plans And Women Focused Cancer Network Will Support Future Upside
Analysts have made a small upward adjustment to the 12 month price target for Apollo Hospitals Enterprise, lifting it from ₹8,771.50 to ₹8,793.50. This change reflects updated views on fair value, profit margins and expected P/E levels.Narrative Update • Mar 12
APOLLOHOSP: Women Focused Cancer Network And Dividend Plans Will Support Future Upside
Analysts have kept their ₹8,771.50 price target for Apollo Hospitals Enterprise unchanged, reflecting consistent assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News A board meeting is scheduled for Feb 10, 2026, at 14:45 Indian Standard Time to review unaudited standalone and consolidated financial results for the three and nine months ended Dec 31, 2025 (company filing).Narrative Update • Feb 25
APOLLOHOSP: Women Focused Cancer Network Will Support Future Upside Potential
Analysts have nudged their fair value estimate for Apollo Hospitals Enterprise slightly higher from ₹8,713.17 to ₹8,771.50, reflecting updated assumptions around revenue growth, profit margins and future P/E levels. What's in the News A board meeting is scheduled on February 10, 2026, at 14:45 Indian Standard Time to review and approve unaudited standalone and consolidated financial results for the three and nine months ended December 31, 2025 (company filing).Analysis Article • Feb 13
Analyst Estimates: Here's What Brokers Think Of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Third-Quarter Report
It's been a good week for Apollo Hospitals Enterprise Limited ( NSE:APOLLOHOSP ) shareholders, because the company has...Analysis Article • Feb 12
Returns Are Gaining Momentum At Apollo Hospitals Enterprise (NSE:APOLLOHOSP)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Narrative Update • Feb 10
APOLLOHOSP: Women Focused Cancer Network Will Support Long Term Upside
Analysts have trimmed their fair value estimate for Apollo Hospitals Enterprise slightly to ₹8,713 per share. This reflects small adjustments to assumptions around the discount rate, revenue growth, profit margins and future P/E expectations.Narrative Update • Jan 27
APOLLOHOSP: Women Focused Cancer Network Will Support Long Term Upside
The analyst fair value estimate for Apollo Hospitals Enterprise has been adjusted slightly, with the target moving from ₹8,735.59 to ₹8,718.34 as analysts factor in a marginally lower revenue growth assumption and a small uplift in expected profit margins, alongside a steady future P/E outlook. What's in the News Apollo Hospitals Enterprise has scheduled a board meeting for February 10, 2026, to review and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, along with other related matters (company filing).Narrative Update • Jan 10
APOLLOHOSP: Expanding Women Focused Cancer Network Will Drive Long Term Upside
Analysts have made a modest upward revision to their price target for Apollo Hospitals Enterprise, with fair value now assessed at ₹8,735.59 compared with the prior ₹8,693.03, reflecting updated views on revenue growth, profit margins and P/E assumptions. What's in the News A board meeting is scheduled for November 6, 2025, to review and approve the unaudited standalone and consolidated financial results for the three and six months ended September 30, 2025, along with other related matters (Key Developments).Analysis Article • Dec 29
Investors Interested In Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) Earnings
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 25x, you may consider Apollo...Narrative Update • Dec 23
APOLLOHOSP: Expanding Women Focused Cancer Network Will Drive Long Term Upside
Narrative Update on Apollo Hospitals Enterprise Analysts have nudged their price target on Apollo Hospitals Enterprise slightly higher to ₹8,693 from ₹8,693, reflecting marginally improved profit margin assumptions and a steady long term earnings multiple despite a modest trim to projected revenue growth. What's in the News Apollo Hospitals Enterprise has scheduled a board meeting for November 6, 2025, to approve unaudited standalone and consolidated financial results for the three and six months ended September 30, 2025, along with other related matters (Key Developments).Narrative Update • Dec 09
APOLLOHOSP: Expanding Women Focused Cancer Network Will Drive Long Term Upside
Analysts have modestly raised their price target on Apollo Hospitals Enterprise to ₹8,692.83 per share, highlighting expectations of sustained robust revenue growth, along with only a marginal adjustment in projected profit margins and valuation multiples. What's in the News Apollo Hospitals has scheduled a board meeting on November 6, 2025 to approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 and to address related matters (company filing).Analysis Article • Nov 27
Is Now The Time To Put Apollo Hospitals Enterprise (NSE:APOLLOHOSP) On Your Watchlist?
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...Narrative Update • Nov 24
APOLLOHOSP: Expanding Oncology Capabilities Will Drive Long-Term Upside
Narrative Update on Apollo Hospitals Enterprise The analyst consensus price target for Apollo Hospitals Enterprise has nudged upward by approximately ₹21, as analysts weigh stable revenue expectations along with a modest shift in projected profit margins and valuation multiples. What's in the News Apollo Hospitals Enterprise will hold a Board Meeting on November 6, 2025, to consider approval of unaudited financial results for the three and six months ended September 30, 2025, and other related matters (Board Meeting).Analysis Article • Nov 12
Here's Why Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Can Manage Its Debt Responsibly
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...Narrative Update • Nov 10
APOLLOHOSP: New Women’s Cancer Centre And Block Deal Will Drive Future Performance
Analysts have raised their price target for Apollo Hospitals Enterprise from ₹8,570.10 to ₹8,671.97, citing modest improvements in projected revenue growth and fair value estimates as reasons for the updated outlook. What's in the News Board meeting scheduled for November 6, 2025 to review and approve unaudited financial results for the recent quarters and discuss other related matters.Analysis Article • Oct 28
Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Experiencing Growth In Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things...Analysis Article • Sep 22
The Price Is Right For Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP)
When close to half the companies in India have price-to-earnings ratios (or "P/E's") below 28x, you may consider Apollo...Analysis Article • Aug 22
Apollo Hospitals Enterprise Limited's (NSE:APOLLOHOSP) CEO Compensation Is Looking A Bit Stretched At The Moment
Key Insights Apollo Hospitals Enterprise to hold its Annual General Meeting on 29th of August CEO Suneeta Reddy's total...Narrative Update • Aug 17
700 New Beds And Digital Health Will Reshape Healthcare Delivery
The upward revision in Apollo Hospitals Enterprise's price target reflects improved profitability, as evidenced by a higher net profit margin and a lower future P/E, resulting in a new consensus fair value of ₹8,587. What's in the News Board meeting scheduled to consider unaudited Q1 FY26 financial results and potential acquisition of Parkway Healthcare's 50% stake in Gleneagles PET-CT Private Limited.Analysis Article • Aug 08
Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Is Paying Out A Dividend Of ₹10.00
The board of Apollo Hospitals Enterprise Limited ( NSE:APOLLOHOSP ) has announced that it will pay a dividend on the...Analysis Article • Aug 01
Is Apollo Hospitals Enterprise (NSE:APOLLOHOSP) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...Analysis Article • Jul 17
Should You Be Adding Apollo Hospitals Enterprise (NSE:APOLLOHOSP) To Your Watchlist Today?
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...Analysis Article • Jun 17
Apollo Hospitals Enterprise (NSE:APOLLOHOSP) Has Announced A Dividend Of ₹10.00
Apollo Hospitals Enterprise Limited's ( NSE:APOLLOHOSP ) investors are due to receive a payment of ₹10.00 per share on...Analysis Article • Jun 03
Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) Full-Year Results: Here's What Analysts Are Forecasting For This Year
Shareholders might have noticed that Apollo Hospitals Enterprise Limited ( NSE:APOLLOHOSP ) filed its annual result...
New Narrative • Nov 18
Critical Facility Expansion And Digital Growth Propel Hospital Industry's Future Revenue Potential
Strategic capacity expansion and urban facility introduction aim to boost revenue growth and profitability through increased patient volumes and occupancy rates.Shareholder Returns
| APOLLOHOSP | IN Healthcare | IN Market | |
|---|---|---|---|
| 7D | -2.2% | -1.9% | 0.4% |
| 1Y | 18.8% | 10.4% | -0.6% |
Return vs Industry: APOLLOHOSP exceeded the Indian Healthcare industry which returned 10.4% over the past year.
Return vs Market: APOLLOHOSP exceeded the Indian Market which returned -0.6% over the past year.
Price Volatility
| APOLLOHOSP volatility | |
|---|---|
| APOLLOHOSP Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in IN Market | 10.3% |
| 10% least volatile stocks in IN Market | 4.8% |
Stable Share Price: APOLLOHOSP has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: APOLLOHOSP's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 42,497 | Suneeta Reddy | www.apollohospitals.com |
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company’s healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities.
Apollo Hospitals Enterprise Limited Fundamentals Summary
| APOLLOHOSP fundamental statistics | |
|---|---|
| Market cap | ₹1.18t |
| Earnings (TTM) | ₹19.42b |
| Revenue (TTM) | ₹252.29b |
60.5x
P/E Ratio4.7x
P/S RatioIs APOLLOHOSP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| APOLLOHOSP income statement (TTM) | |
|---|---|
| Revenue | ₹252.29b |
| Cost of Revenue | ₹160.76b |
| Gross Profit | ₹91.53b |
| Other Expenses | ₹72.11b |
| Earnings | ₹19.42b |
Last Reported Earnings
Mar 31, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | 135.04 |
| Gross Margin | 36.28% |
| Net Profit Margin | 7.70% |
| Debt/Equity Ratio | 56.7% |
How did APOLLOHOSP perform over the long term?
See historical performance and comparisonDividends
0.2%
Current Dividend Yield15%
Payout RatioDoes APOLLOHOSP pay a reliable dividends?
See APOLLOHOSP dividend history and benchmarks| Apollo Hospitals Enterprise dividend dates | |
|---|---|
| Ex Dividend Date | Aug 14 2026 |
| Dividend Pay Date | Sep 10 2026 |
| Days until Ex dividend | 74 days |
| Days until Dividend pay date | 101 days |
Does APOLLOHOSP pay a reliable dividends?
See APOLLOHOSP dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/30 14:43 |
| End of Day Share Price | 2026/05/29 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Apollo Hospitals Enterprise Limited is covered by 48 analysts. 29 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Vikash Singh | 360 ONE Capital Market Private Limited |
| Gaurav Tinani | Ambit Capital |
| Pranav Chawla | Ambit Capital |